Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

NCT00969150 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

362

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Levomilnacipran ER
DRUG: Placebo

Sponsor

Forest Laboratories